John J Sim1, Hui Zhou2, Jiaxiao Shi2, Sally F Shaw2, Shayna L Henry2, Csaba P Kovesdy3, Kamyar Kalantar-Zadeh4, Steven J Jacobsen2. 1. Division of Nephrology and Hypertension, Kaiser Permanente Los Angeles Medical Center, 4700 Sunset Bl, Los Angeles, CA, USA. John.j.sim@kp.org. 2. Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA. 3. Division of Nephrology, University of Tennessee Health Science Center, Memphis, TN, USA. 4. Division of Nephrology and Hypertension, University of California Irvine Medical Center, Irvine, CA, USA.
Abstract
PURPOSE: The early period after chronic kidney disease (CKD) patients transition to end-stage renal disease (ESRD) represents the highest mortality risk but is variable among different patient populations and clinical circumstances. We compared early mortality outcomes among a diverse CKD population that transitioned to ESRD. METHODS: A retrospective cohort study (1/1/2002 through 12/31/2013) of CKD patients (age ≥ 18 years) who transitioned to peritoneal dialysis (PD), hemodialysis (HD) with arteriovenous fistula/grafts, and HD with catheters was performed. Multivariable Cox regression modeling was used to estimate 6-month all-cause mortality hazard ratios (HR) among the three treatment groups after adjustment for patient and clinical characteristics. RESULTS: Among 5373 ESRD patients (62.7 years, 41.3% females, 37.5% Hispanics, 13.3% PD, 34.9% HD with fistula/graft, 51.8% HD with catheter), 551 (10.3%) died at 6 months. Mortality rates were highest immediately after transition (299 deaths per 1000 person-years in first month). Compared to PD patients, the 6-month mortality HR (95% CI) was 1.87 (1.06-3.30) in HD with fistula/graft patients and 3.77 (2.17-6.57) in HD with catheter patients. Inpatient transition (HR 1.32), acute kidney injury (HR 2.06), and an eGFR ≥ 15 vs 5-9 (HR 1.68) at transition were also associated with higher early mortality risk. CONCLUSION: Among a diverse CKD population who transitioned to ESRD, we observed considerable differences in early mortality risk among PD, HD with fistula/graft, and HD with catheter patients. The identification of patient-specific and clinical environmental factors related to high early mortality may provide insights for managing advanced stages of CKD and shared decision making.
PURPOSE: The early period after chronic kidney disease (CKD) patients transition to end-stage renal disease (ESRD) represents the highest mortality risk but is variable among different patient populations and clinical circumstances. We compared early mortality outcomes among a diverse CKD population that transitioned to ESRD. METHODS: A retrospective cohort study (1/1/2002 through 12/31/2013) of CKDpatients (age ≥ 18 years) who transitioned to peritoneal dialysis (PD), hemodialysis (HD) with arteriovenous fistula/grafts, and HD with catheters was performed. Multivariable Cox regression modeling was used to estimate 6-month all-cause mortality hazard ratios (HR) among the three treatment groups after adjustment for patient and clinical characteristics. RESULTS: Among 5373 ESRDpatients (62.7 years, 41.3% females, 37.5% Hispanics, 13.3% PD, 34.9% HD with fistula/graft, 51.8% HD with catheter), 551 (10.3%) died at 6 months. Mortality rates were highest immediately after transition (299 deaths per 1000 person-years in first month). Compared to PDpatients, the 6-month mortality HR (95% CI) was 1.87 (1.06-3.30) in HD with fistula/graft patients and 3.77 (2.17-6.57) in HD with catheter patients. Inpatient transition (HR 1.32), acute kidney injury (HR 2.06), and an eGFR ≥ 15 vs 5-9 (HR 1.68) at transition were also associated with higher early mortality risk. CONCLUSION: Among a diverse CKD population who transitioned to ESRD, we observed considerable differences in early mortality risk among PD, HD with fistula/graft, and HD with catheter patients. The identification of patient-specific and clinical environmental factors related to high early mortality may provide insights for managing advanced stages of CKD and shared decision making.
Authors: David M J Naimark; Morgan E Grams; Kunihiro Matsushita; Corri Black; Iefke Drion; Caroline S Fox; Lesley A Inker; Areef Ishani; Sun Ha Jee; Akihiko Kitamura; Janice P Lea; Joseph Nally; Carmen Alicia Peralta; Dietrich Rothenbacher; Seungho Ryu; Marcello Tonelli; Hiroshi Yatsuya; Josef Coresh; Ron T Gansevoort; David G Warnock; Mark Woodward; Paul E de Jong Journal: J Am Soc Nephrol Date: 2015-12-11 Impact factor: 10.121
Authors: Mae Thamer; James S Kaufman; Yi Zhang; Qian Zhang; Dennis J Cotter; Heejung Bang Journal: Am J Kidney Dis Date: 2015-06-26 Impact factor: 8.860
Authors: Michael V Rocco; Guofen Yan; Jennifer Gassman; Julia Breyer Lewis; Daniel Ornt; Barbara Weiss; Andrew S Levey Journal: Am J Kidney Dis Date: 2002-01 Impact factor: 8.860
Authors: Brian D Bradbury; Rachel B Fissell; Justin M Albert; Mary S Anthony; Cathy W Critchlow; Ronald L Pisoni; Friedrich K Port; Brenda W Gillespie Journal: Clin J Am Soc Nephrol Date: 2006-11-29 Impact factor: 8.237
Authors: Laura Mariani; Bénédicte Stengel; Christian Combe; Ziad A Massy; Helmut Reichel; Danilo Fliser; Roberto Pecoits-Filho; Antonio A Lopes; Kunihiro Yamagata; Takashi Wada; Michelle M Y Wong; Elodie Speyer; Friedrich K Port; Ronald L Pisoni; Bruce M Robinson Journal: Am J Kidney Dis Date: 2016-04-22 Impact factor: 8.860
Authors: Celine Foote; Toshiharu Ninomiya; Martin Gallagher; Vlado Perkovic; Alan Cass; Stephen P McDonald; Meg Jardine Journal: Nephrol Dial Transplant Date: 2012-05-07 Impact factor: 5.992
Authors: James P Lash; Alan S Go; Lawrence J Appel; Jiang He; Akinlolu Ojo; Mahboob Rahman; Raymond R Townsend; Dawei Xie; Denise Cifelli; Janet Cohan; Jeffrey C Fink; Michael J Fischer; Crystal Gadegbeku; L Lee Hamm; John W Kusek; J Richard Landis; Andrew Narva; Nancy Robinson; Valerie Teal; Harold I Feldman Journal: Clin J Am Soc Nephrol Date: 2009-06-18 Impact factor: 8.237
Authors: Bruce M Robinson; Jinyao Zhang; Hal Morgenstern; Brian D Bradbury; Leslie J Ng; Keith P McCullough; Brenda W Gillespie; Raymond Hakim; Hugh Rayner; Joan Fort; Tadao Akizawa; Francesca Tentori; Ronald L Pisoni Journal: Kidney Int Date: 2013-06-26 Impact factor: 10.612
Authors: Kevin S Kim; Emilie P Belley-Côté; Saurabh Gupta; Arjun Pandey; Ali Alsagheir; Ahmad Makhdoum; Graham McClure; Brooke Newsome; Sophie W Gao; Matthias Bossard; Tetsuya Isayama; Yasuhisa Ikuta; Michael Walsh; Amit X Garg; Gordon H Guyatt; Richard P Whitlock Journal: Can J Surg Date: 2022-07-12 Impact factor: 2.840
Authors: Hui Zhou; John J Sim; Simran K Bhandari; Sally F Shaw; Jiaxiao Shi; Scott A Rasgon; Csaba P Kovesdy; Kamyar Kalantar-Zadeh; Michael H Kanter; Steven J Jacobsen Journal: Kidney Int Rep Date: 2018-10-16
Authors: Cheng-Wei Huang; Bonnie H Li; Kristi Reynolds; Steven J Jacobsen; Connie M Rhee; John J Sim Journal: Medicine (Baltimore) Date: 2020-04 Impact factor: 1.817